Literature DB >> 29028993

High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama.

Jodie Dionne-Odom1, William M Geisler1, Kristal J Aaron1, Ken B Waites2, Andrew O Westfall3, Barbara Van Der Pol1, Li Xiao4.   

Abstract

We tested for Mycoplasma genitalium in 157 HIV-infected men. Urogenital and rectal prevalence were 10.8% and 6.4%. Macrolide resistance mutations were detected in 70.6% and 80% of urogenital and rectal samples, and fluoroquinolone resistance mutations in 26.7% and 40%, respectively.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29028993      PMCID： PMC5850425          DOI： 10.1093/cid/cix853

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand.

Authors:  Indira Basu; Sally A Roberts; James E Bower; Gillian Henderson; Murray Reid
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

2.  Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.

Authors:  Tim R H Read; Christopher K Fairley; Sepehr N Tabrizi; Melanie Bissessor; Lenka Vodstrcil; Eric P F Chow; Mieken Grant; Jennifer Danielewski; Suzanne M Garland; Jane S Hocking; Marcus Y Chen; Catriona S Bradshaw
Journal:  Clin Infect Dis       Date:  2016-10-24       Impact factor: 9.079

3.  Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.

Authors:  Yang Li; Wen-Jing Le; Sai Li; Yu-Ping Cao; Xiao-Hong Su
Journal:  Int J STD AIDS       Date:  2017-01-24       Impact factor: 1.359

4.  Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis.

Authors:  Arabella Touati; Olivia Peuchant; Jorgen S Jensen; Cécile Bébéar; Sabine Pereyre
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

5.  Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.

Authors:  Yuko Yamaguchi; Masaya Takei; Ryuta Kishii; Mitsuru Yasuda; Takashi Deguchi
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 6.  Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections.

Authors:  Lisa E Manhart; Jørgen Skov Jensen; Catriona S Bradshaw; Matthew R Golden; David H Martin
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

7.  Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France.

Authors:  Chloé Le Roy; Nadège Hénin; Sabine Pereyre; Cécile Bébéar
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

8.  Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States.

Authors:  Damon Getman; Alice Jiang; Meghan O'Donnell; Seth Cohen
Journal:  J Clin Microbiol       Date:  2016-06-15       Impact factor: 5.948

9.  Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.

Authors:  Gerald L Murray; Catriona S Bradshaw; Melanie Bissessor; Jennifer Danielewski; Suzanne M Garland; Jørgen S Jensen; Christopher K Fairley; Sepehr N Tabrizi
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

10.  Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.

Authors:  Elena Shipitsyna; Tatiana Rumyantseva; Daniel Golparian; Guzel Khayrullina; Amaya C Lagos; Inna Edelstein; Kai Joers; Jörgen S Jensen; Alevtina Savicheva; Natalia Rudneva; Larisa Sukhanova; Roman Kozlov; Alexander Guschin; Magnus Unemo
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240
View more
  17 in total

Review 1.  Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections.

Authors:  Faye Korich; Neha G Reddy; Maria Trent
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

2.  Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama.

Authors:  Li Xiao; Ken B Waites; Barbara Van Der Pol; Kristal J Aaron; Edward W Hook; William M Geisler
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

3.  Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study.

Authors:  Brandie D Taylor; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Toni Darville
Journal:  Sex Transm Infect       Date:  2018-03-21       Impact factor: 3.519

4.  Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis.

Authors:  Laura C Chambers; Jørgen S Jensen; Jennifer L Morgan; M Sylvan Lowens; Sarah S Romano; Patricia A Totten; Olusegun O Soge; James P Hughes; Matthew R Golden; Lisa E Manhart
Journal:  Sex Transm Dis       Date:  2019-12       Impact factor: 2.830

5.  Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Badalona, Spain.

Authors:  Belén Rivaya; Chloé Le Roy; Elena Jordana-Lluch; Gema Fernández-Rivas; Cristina Casañ; Victoria González; Jun Hao Wang-Wang; Cécile Bébéar; Lurdes Matas; Sabine Pereyre
Journal:  Antibiotics (Basel)       Date:  2022-04-05

6.  Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

Authors:  E L Sweeney; E Trembizki; C Bletchly; C S Bradshaw; A Menon; F Francis; J Langton-Lockton; G R Nimmo; D M Whiley
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

7.  Brazilian Protocol for Sexually Transmitted Infections, 2020: infections that cause urethral discharge.

Authors:  Leonor Henriette de Lannoy; Roberto José de Carvalho da Silva; Edilbert Pellegrini Nahn Júnior; Eduardo Campos de Oliveira; Pâmela Cristina Gaspar
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

8.  In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium.

Authors:  Jørgen Skov Jensen; Christina Nørgaard; Nicole Scangarella-Oman; Magnus Unemo
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.

Authors:  Tim R H Read; Christopher K Fairley; Gerald L Murray; Jorgen S Jensen; Jennifer Danielewski; Karen Worthington; Michelle Doyle; Elisa Mokany; Litty Tan; Eric P F Chow; Suzanne M Garland; Catriona S Bradshaw
Journal:  Clin Infect Dis       Date:  2019-02-01       Impact factor: 9.079

10.  Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?

Authors:  Ellen F Eaton; Erika L Austin; Catherine K Dodson; Jose P Heudebert; D'Netria Jackson; Christina A Muzny
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.